• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种便携式国际标准化比值监测仪在接受低分子肝素桥接治疗以等待充分口服抗凝疗效的患者中的准确性。

Accuracy of a portable international normalized ratio monitor for patients receiving a low molecular weight heparin as a bridge pending full oral anticoagulant efficacy.

机构信息

Les Grands Prés - Centre de réadaptation Cardiaque de la Brie 27 rue Sainte Christine 77174 Villeneuve-Saint-Denis, France.

出版信息

Thromb Res. 2010 Feb;125(2):192-5. doi: 10.1016/j.thromres.2009.09.004. Epub 2009 Nov 25.

DOI:10.1016/j.thromres.2009.09.004
PMID:19942256
Abstract

BACKGROUND

Point of care (POC) devices measuring the international normalized ratio (INR) are accurate for patients with stable disease, but their efficiency has not been prospectively assessed during the "bridging period" when patients are receiving a low molecular weight heparin (LMWH) on top of a vitamin K antagonist (VKA) until the target INR is reached.

METHODS

188 dual INR measurement using the POC (INR(POC)) and the laboratory (INR(lab)) at the same time were consecutively determined : 69 in patients receiving LMWH+VKA (bridging group) and 119 in patients receiving only a VKA (control group). INRpoc was compared to INR(lab).

RESULTS

Test strip failure rate was higher in the bridging group than in the control group (29% vs 4%; p<0,001). In successful tests, POC accuracy was not modified by LMWH administration: the correlation coefficients between POC and lab INR values for the bridging group and the control group were 0,81 and 0,87 respectively, and the relative measure of divergence (RMD=INR(lab) - INR(poc)/INR(lab)) was lower in the bridging group than in the control group (4+/-7% vs 10+/-14%; p=0,02). Finally, clinically relevant agreement between POC and laboratory was of 90% in the bridging group and 92.1% in the control group (p=0.6).

CONCLUSION

With the POC used (INRatio), in patients receiving LMWH when the POC gives a result, it is as accurate as in patients not receiving a LMWH.

摘要

背景

即时检测(POC)设备在测量国际标准化比值(INR)时,对于病情稳定的患者是准确的,但它们在“桥接期”的效率尚未得到前瞻性评估,在此期间,患者在接受维生素 K 拮抗剂(VKA)的同时还接受低分子肝素(LMWH),直到达到目标 INR 为止。

方法

连续对 188 例同时进行 POC(INR(POC)) 和实验室(INR(lab)) 双重 INR 测量:69 例接受 LMWH+VKA 的患者(桥接组)和 119 例仅接受 VKA 的患者(对照组)。比较 INRpoc 与 INR(lab)。

结果

桥接组的检测条失败率高于对照组(29%比 4%;p<0.001)。在成功的测试中,LMWH 的给药并未改变 POC 的准确性:桥接组和对照组 POC 和实验室 INR 值之间的相关系数分别为 0.81 和 0.87,桥接组的相对偏差(RMD=INR(lab) - INR(poc)/INR(lab))低于对照组(4+/-7%比 10+/-14%;p=0.02)。最后,桥接组 POC 和实验室之间的临床相关一致性为 90%,对照组为 92.1%(p=0.6)。

结论

在接受 LMWH 的患者中,当 POC 给出结果时,其与未接受 LMWH 的患者一样准确。

相似文献

1
Accuracy of a portable international normalized ratio monitor for patients receiving a low molecular weight heparin as a bridge pending full oral anticoagulant efficacy.一种便携式国际标准化比值监测仪在接受低分子肝素桥接治疗以等待充分口服抗凝疗效的患者中的准确性。
Thromb Res. 2010 Feb;125(2):192-5. doi: 10.1016/j.thromres.2009.09.004. Epub 2009 Nov 25.
2
Low-molecular-weight heparin may alter point-of-care assay for international normalized ratio.低分子量肝素可能会改变国际标准化比值的即时检测。
Pharmacotherapy. 2005 Oct;25(10):1341-7. doi: 10.1592/phco.2005.25.10.1341.
3
Differential inhibition of thrombin generation by vitamin K antagonists alone and associated with low-molecular-weight heparin.维生素K拮抗剂单独使用及与低分子量肝素联合使用时对凝血酶生成的差异抑制作用。
Thromb Haemost. 2009 Jul;102(1):42-8. doi: 10.1160/TH08-10-0653.
4
Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.CoaguChek XS用于需要华法林治疗的儿童即时国际标准化比值(INR)测量的准确性。
Thromb Haemost. 2008 Jun;99(6):1097-103. doi: 10.1160/TH07-10-0634.
5
A comparison of point-of-care instruments designed for monitoring oral anticoagulation with standard laboratory methods.用于监测口服抗凝治疗的即时检验仪器与标准实验室方法的比较。
Thromb Haemost. 2000 May;83(5):698-703.
6
Feasibility, cost-effectiveness and patients' acceptance of point-of-care INR testing in a hospital-based anticoagulation clinic.基于医院的抗凝门诊中即时国际标准化比值(INR)检测的可行性、成本效益及患者接受度
Ann Hematol. 2008 Nov;87(11):905-10. doi: 10.1007/s00277-008-0530-8. Epub 2008 Jul 5.
7
Clinical impact of point-of-care vs laboratory measurement of anticoagulation.即时检测与实验室检测抗凝指标的临床影响
Am J Clin Pathol. 2005 Feb;123(2):184-8.
8
Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system.新型小体积凝血监测仪的性能评估:SmartCheck INR系统
Am J Clin Pathol. 2008 Mar;129(3):500-4. doi: 10.1309/K87FWL7UA8H8ANHR.
9
[Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].[全膝关节置换术后低分子肝素与华法林联合抗凝治疗的并发症及风险——我们的经验]
Acta Chir Orthop Traumatol Cech. 2004;71(4):237-44.
10
Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).儿童口服抗凝治疗的床旁监测。使用国际参考凝血活酶制剂(rTF/95)对CoaguChek XS系统与静脉血国际标准化比值(INR)及静脉血INR进行比较。
Thromb Haemost. 2009 Jul;102(1):159-65. doi: 10.1160/TH09-01-0056.